HCS
RLAY icon

Himension Capital (Singapore)’s Relay Therapeutics RLAY Stock Holding History

Himension Capital (Singapore)’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$938K Sell
50,111
-44,058
-47% -$640K 0.06% 107
2026
Q1 		$937K Sell
94,169
-10,784
-10% -$96.5K 0.07% 79
2025
Q4 		$888K Buy
+104,953
New +$749K 0.05% 78

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Himension Capital (Singapore)'s RLAY Position: Q2 2026 in Review

Himension Capital (Singapore) reduced its Relay Therapeutics (RLAY) stake by 47% in Q2 2026, selling an estimated $640K and leaving 50,111 shares worth $938K. The position accounts for 0.06% of the portfolio, ranked #107.

Himension Capital (Singapore) first reported a position in RLAY in Q4 2025 and has held it in 3 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Himension Capital (Singapore) held 50,111 shares of Relay Therapeutics worth $938K as of Q2 2026.
  • Himension Capital (Singapore) sold 44,058 Relay Therapeutics shares in Q2 2026, an estimated $640K.
  • Relay Therapeutics made up 0.06% of Himension Capital (Singapore)'s portfolio in Q2 2026, its #107 holding.
  • Himension Capital (Singapore) first reported a position in Relay Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Himension Capital (Singapore)'s 13F filing for Q2 2026, filed 13 Aug 2026.